Top-News
Mittwoch,
20.08.2014 23:10
von
PR Newswire
| Aufrufe: 66
Second Quarter And Six Months 2014 Financial Results Released By Inrad Optics, Inc.
Ein Arzt berät einen Patienten (Symbolbild).
© TommL / Vetta / Getty Images
https://www.gettyimages.de/
PR Newswire
NORTHVALE, N.J., Aug. 20, 2014
NORTHVALE, N.J., Aug. 20, 2014 /PRNewswire/ -- Inrad Optics, Inc. (OTCBB: INRD) has reported its consolidated financial results for its second quarter and six months ended June 30, 2014.
Revenue for the second quarter was $2.2 million, down 17.3% from $2.7 million in the same period last year. For the six months ended June 30, 2014, revenue was $4.1 million compared to $5.8 million for the comparable period last year as the Company experienced a decrease in shipments in the defense and university & national labs markets. Increased shipments in laser systems and process control & metrology markets partially offset the overall decline. Sales to the Company's top five customers represented approximately 47% of sales in six months ended June 30, 2014, compared to 35% last year.
Orders were $5.4 million and $4.8 million for the six months ended June 30, 2014 and 2013, respectively, an increase of 12.5%.
Gross profit for the second quarter of 2014 was $(141,000) including restructuring costs of $62,000, or (6.3%) of sales, versus $308,000 or 11.4% in the comparable quarter last year. For the six months ended June 30, 2014, gross profit decreased to $(277,000) including $121,000 of restructuring costs, or (6.7%) of sales compared to $1.0 million or 17.4% in 2013. The 2014 decrease in gross profit margin primarily reflects a lower and less profitable sales mix compared to 2013. The six months ended June 30, 2013 was favorably impacted by payroll savings of approximately $79,000, net of severance and other separation costs, related to a reduction in work-force.
The Company had a net loss of $(1,031,000) and $(1,906,000) for the three and six months ended June 30, 2014. This compares with a net loss of $(648,000) and $(817,000) in the comparable periods last year. Net loss per share was $(0.08) and $(0.16), basic and diluted, for the three months and six months ended June 30, 2014. For the three and six months ended June 30, 2013, the basic and diluted net loss per share was $(0.05) and $(0.07), respectively.
Net cash used in operating activities was $1,121,000 for the six months ended June 30, 2014 compared to net cash used of $134,000 last year. The difference primarily reflects the impact of the higher net loss in the six months ended June 30, 2014.
Investing activities in the six months ended June 30, 2014 include capital expenditures of $363,000 primarily related to the consolidation of the Florida operation in Northvale, NJ, net of proceeds from the sale of plant and equipment of $78,000. This compared with capital expenditures of $447,000 in the same period last year related mainly to the purchase of a plasma assist optical coating chamber and related expenditures for additional equipment and installation.
After investing and financing activities, net cash decreased by $1,492,000 versus a decrease of $624,000 last year. At June 30, 2014, the Company had cash and cash equivalents of $960,000.
President and CEO Amy Eskilson remarked "Our Q2 results, while unfavorable, represent a predicted function of our one-time consolidation costs and reduced shipments to our defense and university segment customers. Much more positively, I am pleased to report orders are up 15% in 2014 over the same period in 2013, resulting in a backlog that is up over $1.2 million or 28% from the start of the year. We continue to be successful at diversifying our customer base, represented by new orders in the medical, commercial sensing and inspection markets. Operationally, facility integration efforts are paying off and cost savings are being realized.
Additionally, the development and commercialization of the nuclear detection crystal stilbene continues to demonstrate success. In June, we were honored with two significant awards – a coveted SBIR Tibbetts Award from the Small Business Association, and an award from the US Department of Homeland Security's Domestic Nuclear Detection Office."
Inrad Optics, Inc. was incorporated in New Jersey in 1973. The Company develops, manufactures and markets products and services for use in photonics industry sectors via three distinct but complimentary product areas - "Crystals and Devices", "Custom Optics" and "Metal Optics."
The Company is a vertically integrated organization specializing in crystal-based optical components and devices, custom optical components from both glass and metal, and precision optical and opto-mechanical assemblies. Manufacturing capabilities include solution and high temperature crystal growth, extensive optical fabrication capabilities, including precision diamond turning and the ability to handle large substrates, optical coatings and in-process metrology expertise. Inrad Optics' customers include leading corporations in the defense, aerospace, laser systems, process control and metrology sectors of the photonics industry, as well as the U.S. Government, National Laboratories and Universities worldwide.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this press release that are not purely historical are forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These statements may be identified by their use of forward-looking terminology such as "believes", "expects", "should", "will", "plan", "anticipate", "probably", "targeting" or similar words. Such forward-looking statements, such as our expectation for revenues, new orders, and improved results involve risks and uncertainties that could cause actual results to differ materially from those projected. Risks and uncertainties that could cause actual results to differ materially from such forward looking statements are, but are not limited to, uncertainties in market demand for the company's products or the products of its customers, future actions by competitors, inability to deliver product on time, inability to develop new business, inability to retain key employees or hire new employees, and other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission including our Annual Report on Form 10-K for the year ended December 31, 2013. The forward looking statements made in this news release are made as of the date hereof and Inrad Optics, Inc. does not assume any obligation to update publicly any forward looking statement.
| INRAD OPTICS, INC AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
| | | | | | | ||
| | | June 30, | | December 31, | | ||
| | | 2014 | | 2013 | | ||
| | | (Unaudited) | | (Audited) | | ||
| | | | | | | ||
| Assets | | | | | | ||
| Current assets: | | | | | | ||
| Cash and cash equivalents | | $ | 959,636 | | $ | 2,451,263 | |
| Accounts receivable (net of allowance for doubtful accounts of $15,000 in 2014 and 2013) | | 1,121,043 | | 1,236,958 | | ||
| Inventories, net | | 2,917,718 | | 3,129,855 | | ||
| Other current assets | | 103,409 | | 144,581 | | ||
| Total current assets | | 5,101,806 | | 6,962,657 | | ||
| Plant and equipment: | | | | | | ||
| Plant and equipment, at cost | | 15,674,367 | | 15,638,759 | | ||
| Less: Accumulated depreciation and amortization | | (13,874,280) | | (13,931,775) | | ||
| Total plant and equipment | | 1,800,087 | | 1,706,984 | | ||
| Precious Metals | | 483,676 | | 474,960 | | ||
| Goodwill | | 311,572 | | 311,572 | | ||
| Intangible Assets, net | | 319,479 | | 358,760 | | ||
| Other Assets | | 33,122 | | 33,122 | | ||
|
Total Assets | | $ | 8,049,742 | | $ | 9,848,055 | |
| | | | | | | ||
| Liabilities and Shareholders' Equity | | | | | | ||
| Current Liabilities: | | | | | | ||
| Current portion of other long term notes | | $ | 156,600 | | $ | 156,600 | |
| Accounts payable and accrued liabilities | | 919,537 | | 967,963 | | ||
| Customer advances | | 251,370 | | 146,784 | | ||
| Total current liabilities | | 1,327,507 | | 1,271,347 | | ||
| | | | | | | ||
| Related Party Convertible Notes Payable | | 2,500,000 | | 2,500,000 | | ||
| | | | | | | ||
| Other Long Term Notes, net of current portion | | 635,339 | | 712,868 | | ||
| Total liabilities | | 4,462,846 | | 4,484,215 | | ||
| | | | | | | ||
| Commitments | | | | | | ||
| | | | | | | ||
| Shareholders' Equity: | | | | | | ||
| Common stock: $.01 par value; 60,000,000 authorized shares; | | 123,543 Werbung Mehr Nachrichten zur INRAD INC Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE (Mit der Bestellung akzeptierst du die Datenschutzhinweise) -1  Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink. Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte. Andere Nutzer interessierten sich auch für folgende News | |||||
